Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

Biogen Inc. and Biogen MA Inc. (“Biogen”) filed a Complaint for Declaratory Judgment and Permanent Injunctive Relief ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Most gardeners grow culinary sage for its aromatic leaves, which can be used to flavor roasted dishes, soups, and other savory treats, but sage is a versatile herb that can also be cultivated as ...

UPDATE: Four suspects arrested in connection to the deadly shooting at Sage Park appeared in court Friday for their bond hearings. Nineteen-year-old Jaquentin Brantley, 18-year-old Roderiquez ...

Learn about drug types, stages, administration routes, and molecular classifications. Explore therapies under development, emerging drugs, and key pl ...

Cell and gene therapy start-up NKure Therapeutics and international gene-editing company CRISPR Therapeutics have entered into a partnership to co-develop and co-commercialise CTX112 — a next ...

To identify therapeutic agents that exploit this SHOC2 dependency, the authors investigated the interaction between SHOC2 and NRAS with a glutamine to arginine mutation at position 61 (NRASQ61R).

Mersana Therapeutics only has eyes for Emi-Le. Seeking to extend its cash runway into mid-2026, the biotech is laying off 55% of its employees and cutting back internal R&D work to focus on lead ...